Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-08-01

Clinical Trial Update: Memantine in Body Focused Repetitive Behaviors [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating memantine for body-focused repetitive behaviors (trichotillomania and excoriation disorder) has completed, with results posted on 2023-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Memantine (memantine)

Snippet

Sponsor: University of Chicago | Conditions: Trichotillomania (Hair-Pulling Disorder), Dermatillomania | Phase 2 | Status: COMPLETED | Results posted: 2023-08-01